Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
05/05/2026 13:37
May 5 (Reuters) - Microbot Medical Inc MBOT.O: MICROBOT MEDICAL®’S LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM IS NOW ADOPTED BY MULTIPLE ACCOUNTS ACROSS KEY TERRITORIES INCLUDING TWO ACCESS-PVI PIVOTAL CLINICAL TRIAL SITES Source text: ID:nGNX2TJQlV Further company coverage: MBOT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones